Active — Not RecruitingNot Applicable

Out of State - tAN hEDS

United States30 participantsStarted 2024-11-27

Plain-language summary

Hypermobile EDS and hypermobile spectrum disorder (collectively referred to as hEDS) are estimated to affect 1 in 500 individuals worldwide. hEDS patients have limited treatment options for their numerous symptoms that impact the quality of life. This clinical trial tests a new ear stimulation method in hEDS patients to determine if it may improve quality of life.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Ages of 18 and 65; * Participants who meet the 2017 diagnostic criteria for hEDS or HSD4-5 with persistent symptoms in at least two of the domains to be followed during the intervention (pain, fatigue, sleep, anxiety, depression, quality of life, GI function, autonomic function and immune function) * Mentally capable of reading, writing, giving consent, and following instructions; Exclusion Criteria: * Mentally capable of reading, writing, giving consent, and following instructions; * Not pregnant; * No history of seizures; * no prior history of trauma or damage to ear * History of documented Autism spectrum disorder (ASD) diagnosis * Residing in the state of South Carolina

What they're measuring

Ehlers-Danlos Syndrome Symptom Battery

Timeframe: 4 weeks

Trial details

NCT IDNCT06548594

SponsorMedical University of South Carolina

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-01

View on ClinicalTrials.gov More Hypermobile EDS (hEDS) trials